DJ-1/PARK7: A New Therapeutic Target for Neurodegenerative Disorders. [electronic resource]
- Biological & pharmaceutical bulletin 2017
- 548-552 p. digital
Publication Type: Journal Article; Review
1347-5215
10.1248/bpb.b16-01006 doi
Animals Antiparkinson Agents--therapeutic use Humans Neurodegenerative Diseases--drug therapy Parkinson Disease--drug therapy Protein Deglycase DJ-1--drug effects